Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis.

Amyotrophic lateral sclerosis metabolomics mitochondria dysfunction muscle transcriptomics

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
02 Jun 2022
Historique:
received: 20 04 2022
revised: 30 05 2022
accepted: 30 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Diverse biomarkers and pathological alterations have been found in muscle of patients with Amyotrophic lateral sclerosis (ALS), but the relation between such alterations and dysfunction in energetic metabolism remains to be investigated. We established the metabolome of muscle and serum of ALS patients and correlated these findings with the clinical status and pathological alterations observed in the muscle. We obtained data from 20 controls and 17 ALS patients (disease duration: 9.4 ± 6.8 months). Multivariate metabolomics analysis identified a distinct serum metabolome for ALS compared to controls (p-CV-ANOVA < 0.035) and revealed an excellent discriminant profile for muscle metabolome (p-CV-ANOVA < 0.0012). Citramalate was discriminant for both muscle and serum. High lauroylcarnitine levels in muscle were associated with low Forced Vital Capacity. Transcriptomics analysis of key antioxidant enzymes showed an upregulation of SOD3 (p = 0.0017) and GLRX2(1) (p = 0.0022) in ALS muscle. Analysis of mitochondrial enzymatic activity in muscle revealed higher complex II/CS (p = 0.04) and lower LDH (p = 0.03) activity in ALS than in controls. Our study showed, for the first time, a global dysfunction in the muscle of early-stage ALS patients. Furthermore, we identified novel metabolites to be employed as biomarkers for diagnosis and prognosis of ALS patients.

Identifiants

pubmed: 35740329
pii: biomedicines10061307
doi: 10.3390/biomedicines10061307
pmc: PMC9220134
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : ARSLA
ID : METABOMU
Organisme : Fondation Brou de Lauriere
ID : METABOMU

Références

FASEB J. 2015 Apr;29(4):1314-28
pubmed: 25491309
Brain Pathol. 2016 Mar;26(2):227-36
pubmed: 26780251
Exp Neurol. 2021 May;339:113620
pubmed: 33497646
Eur Neurol. 1998;39(3):141-7
pubmed: 9605390
J Neurosci. 2008 Apr 16;28(16):4115-22
pubmed: 18417691
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 8;97:109771
pubmed: 31669200
Genes (Basel). 2020 May 11;11(5):
pubmed: 32403313
Cell Metab. 2016 Apr 12;23(4):635-48
pubmed: 26924217
Neurobiol Dis. 2010 Mar;37(3):673-81
pubmed: 20025971
Biogerontology. 2015 Aug;16(4):485-501
pubmed: 25801590
J Cereb Blood Flow Metab. 2019 Sep;39(9):1710-1724
pubmed: 29553298
Bioinformatics. 2008 Jan 15;24(2):282-4
pubmed: 18006545
Curr Med Chem. 2014;21(31):3551-75
pubmed: 25245510
J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1329-1338
pubmed: 32928939
Diabetes. 1976 Nov;25(11):1055-65
pubmed: 992226
J Anim Sci Biotechnol. 2017 Jan 23;8:10
pubmed: 28127425
Scand J Clin Lab Invest. 1976 Oct;36(6):547-52
pubmed: 137518
Curr Opin Clin Nutr Metab Care. 2017 Jul;20(4):237-242
pubmed: 28375879
Sci Rep. 2021 Oct 21;11(1):20786
pubmed: 34675267
J Neurochem. 2001 Feb;76(3):910-8
pubmed: 11158263
J Lipid Res. 2007 Jul;48(7):1571-80
pubmed: 17438338
EMBO Mol Med. 2015 Mar 27;7(5):526-46
pubmed: 25820275
Int J Mol Sci. 2021 Jun 14;22(12):
pubmed: 34198557
J Pharmacol Sci. 2008 Nov;108(3):227-38
pubmed: 19008644
Anal Bioanal Chem. 2015 Nov;407(29):8861-72
pubmed: 26446897
J Pharm Biomed Anal. 2018 Jan 30;148:273-279
pubmed: 29059617
Lung. 2011 Aug;189(4):311-21
pubmed: 21567165
Clin Sci (Lond). 1983 Jun;64(6):601-9
pubmed: 6340918
J Med Chem. 2009 Sep 10;52(17):5442-8
pubmed: 19670830
Neurobiol Dis. 2008 Oct;32(1):133-41
pubmed: 18652897
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1046-57
pubmed: 16024877
Redox Biol. 2018 Jul;17:367-376
pubmed: 29857311
Neurology. 1966 May;16(5):475-81
pubmed: 5949060
Mol Nutr Food Res. 2018 Mar;62(6):e1700756
pubmed: 29377510
Brain. 2005 Aug;128(Pt 8):1870-6
pubmed: 15901649
Neurology. 1992 Aug;42(8):1532-4
pubmed: 1641148
Sci Rep. 2020 Aug 3;10(1):12998
pubmed: 32747678
Curr Alzheimer Res. 2021;18(10):787-801
pubmed: 34493184
Neurology. 1993 Dec;43(12):2466-70
pubmed: 8255440
Cells. 2020 Apr 24;9(4):
pubmed: 32344665
Mol Neurobiol. 2017 Sep;54(7):5361-5374
pubmed: 27590138
Mol Biosyst. 2014 Oct;10(10):2538-51
pubmed: 25010571
Neurology. 2008 Mar 25;70(13):1004-9
pubmed: 18199832
Neuropathol Appl Neurobiol. 2007 Apr;33(2):204-11
pubmed: 17359361
Rev Neurol (Paris). 2021 May;177(5):544-549
pubmed: 33781562
Neurodegener Dis. 2014;13(1):29-37
pubmed: 24021858
Curr Genet Med Rep. 2017 Jun;5(2):108-114
pubmed: 29057168
Sci Rep. 2020 Aug 31;10(1):14302
pubmed: 32868812
Presse Med. 2012 Jun;41(6 Pt 1):560-74
pubmed: 22137288
PLoS One. 2016 Dec 22;11(12):e0168812
pubmed: 28005991
Muscle Nerve. 2018 May;57(5):735-741
pubmed: 29105161
J Biol Chem. 2006 Sep 29;281(39):28648-56
pubmed: 16880213
Muscle Nerve. 2021 Sep;64(3):346-351
pubmed: 34076262
Arch Neurol. 1979 Feb;36(2):74-80
pubmed: 420626
Neurobiol Dis. 2016 Apr;88:148-60
pubmed: 26805387
Antioxidants (Basel). 2020 Dec 10;9(12):
pubmed: 33321938
Bioinformatics. 2010 Sep 15;26(18):2342-4
pubmed: 20628077
Hum Mol Genet. 2014 Sep 15;23(18):4995-5008
pubmed: 24833719
Front Endocrinol (Lausanne). 2020 May 05;11:212
pubmed: 32431666
Nature. 2019 Aug;572(7770):474-480
pubmed: 31330533
Pharmacol Rep. 2013;65(2):288-304
pubmed: 23744414
Acta Neuropathol Commun. 2014 Dec 14;2:165
pubmed: 25510661
Ann Neurol. 2002 Nov;52(5):623-7
pubmed: 12402260
ASN Neuro. 2021 Jan-Dec;13:1759091421994351
pubmed: 33557592
PLoS One. 2013 Nov 20;8(11):e80748
pubmed: 24278317
J Epidemiol. 2015;25(6):445-51
pubmed: 25947580
Neurotherapeutics. 2016 Oct;13(4):905-917
pubmed: 27444617
PLoS One. 2015 Oct 29;10(10):e0141572
pubmed: 26513461
Molecules. 2021 Jul 06;26(14):
pubmed: 34299389
Neurology. 1996 Nov;47(5):1220-6
pubmed: 8909433
Expert Rev Neurother. 2020 Sep;20(9):907-919
pubmed: 32583696
Amyotroph Lateral Scler. 2010;11(1-2):166-71
pubmed: 20184518
Mitochondrion. 2009 Sep;9(5):331-9
pubmed: 19439198
Front Neurosci. 2020 Jul 15;14:679
pubmed: 32760239
Int J Biol Macromol. 2013 Oct;61:212-7
pubmed: 23872456
Biochem Soc Trans. 1988 Jun;16(3):420-2
pubmed: 3053290
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):478-84
pubmed: 26161993
Neurobiol Dis. 2006 Jun;22(3):599-610
pubmed: 16616851
J Neurol Sci. 1999 Oct 31;169(1-2):133-9
pubmed: 10540022
Semin Cell Dev Biol. 2021 Apr;112:69-81
pubmed: 32962914
Hum Mol Genet. 2010 Nov 15;19(22):4529-42
pubmed: 20829229
PLoS One. 2012;7(6):e38812
pubmed: 22701716
Front Neurol. 2018 Dec 18;9:1126
pubmed: 30619076
Eur Respir J. 1998 Sep;12(3):641-5
pubmed: 9762793
Microb Pathog. 2021 Nov;160:105187
pubmed: 34530073
Biol Res Nurs. 2018 Oct;20(5):513-521
pubmed: 29925252
Cell Biosci. 2021 Jan 11;11(1):14
pubmed: 33431046
Biochim Biophys Acta. 2009 Aug;1791(8):806-15
pubmed: 19465148
Brain. 2020 Dec 1;143(12):3603-3618
pubmed: 33439988
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4028-33
pubmed: 20160114
J Proteome Res. 2020 Aug 7;19(8):3276-3285
pubmed: 32418425
Brain. 2000 Jul;123 ( Pt 7):1339-48
pubmed: 10869047
J Neurol Sci. 1998;156(1):65-72
pubmed: 9559989
Neuroimmunomodulation. 2021;28(4):204-212
pubmed: 34175843
J Neurosci. 2002 Mar 15;22(6):RC215
pubmed: 11886899
Antioxid Redox Signal. 2009 Nov;11(11):2685-700
pubmed: 19558212
J Biol Chem. 2016 Aug 12;291(33):17197-208
pubmed: 27261461
Mol Biosyst. 2017 Jan 31;13(2):371-379
pubmed: 28059425
J Neurol. 1989 Dec;236(8):445-7
pubmed: 2614487
Ultrastruct Pathol. 2002 Jan-Feb;26(1):3-7
pubmed: 12028652
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
FASEB J. 2003 Nov;17(14):2091-3
pubmed: 14500553
Brain Res. 1992 Apr 3;576(2):337-8
pubmed: 1515928
J Neuropathol Exp Neurol. 2007 Jan;66(1):10-6
pubmed: 17204932
Neurology. 1968 Sep;18(9):915-25
pubmed: 4301063
Curr Opin Clin Nutr Metab Care. 2001 Sep;4(5):433-7
pubmed: 11568506
J Biol Chem. 2007 Nov 9;282(45):32640-54
pubmed: 17848555
J Proteome Res. 2015 Dec 4;14(12):5273-82
pubmed: 26538324
Sci Rep. 2017 Jan 19;7:41059
pubmed: 28102336
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Nov 1;1130-1131:121822
pubmed: 31669633
Clin Chim Acta. 2010 Apr 2;411(7-8):563-7
pubmed: 20096678
Can J Neurol Sci. 1979 May;6(2):105-12
pubmed: 487296
Dis Model Mech. 2019 Aug 16;12(8):
pubmed: 31439573
BMC Neurol. 2012 Dec 23;12:160
pubmed: 23259505
Mol Neurobiol. 2019 Apr;56(4):2394-2407
pubmed: 30030751
J Neuroinflammation. 2020 Oct 15;17(1):303
pubmed: 33059700
J Neurol Sci. 2011 Jul 15;306(1-2):76-81
pubmed: 21496826
J Neurol Sci. 1984 Mar;63(3):317-24
pubmed: 6374040
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891-5
pubmed: 10988101
Antioxid Redox Signal. 2019 Apr 1;30(10):1352-1368
pubmed: 29183158

Auteurs

Débora Lanznaster (D)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.

Clément Bruno (C)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Biochimie et Biologie Moléculaire, CHU de Tours, 37000 Tours, France.

Jérôme Bourgeais (J)

CNRS ERL7001, EA 7501 GICC, Université de Tours, 37000 Tours, France.

Patrick Emond (P)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Médecine Nucléaire In Vitro, CHU de Tours, 37000 Tours, France.

Ilyess Zemmoura (I)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Neurochirurgie, CHU de Tours, 37000 Tours, France.

Antoine Lefèvre (A)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.

Pascal Reynier (P)

Service de Biochimie et Biologie Moléculaire, CHU d'Angers, 49000 Angers, France.
Mitovasc-Mitolab, UMR CNRS6015-INSERM1083, 49000 Angers, France.

Sébastien Eymieux (S)

Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHU de Tours, 37000 Tours, France.
INSERM U1259, Université de Tours, 37000 Tours, France.

Emmanuelle Blanchard (E)

Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHU de Tours, 37000 Tours, France.
INSERM U1259, Université de Tours, 37000 Tours, France.

Patrick Vourc'h (P)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Biochimie et Biologie Moléculaire, CHU de Tours, 37000 Tours, France.

Christian R Andres (CR)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Biochimie et Biologie Moléculaire, CHU de Tours, 37000 Tours, France.

Salah Eddine Bakkouche (SE)

Service de Chirurgie Orthopédique et Traumatique, CHU de Tours, 37000 Tours, France.

Olivier Herault (O)

CNRS ERL7001, EA 7501 GICC, Université de Tours, 37000 Tours, France.

Luc Favard (L)

Service de Neurologie, CHU de Tours, 37000 Tours, France.

Philippe Corcia (P)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Neurologie, CHU de Tours, 37000 Tours, France.

Hélène Blasco (H)

UMR 1253, iBrain, Université de Tours, INSERM, 37000 Tours, France.
Service de Biochimie et Biologie Moléculaire, CHU de Tours, 37000 Tours, France.

Classifications MeSH